Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Current research explores hair growth drugs, while future research aims for personalized treatments.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Finasteride doesn't affect bone density in male rats.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Finasteride doesn't affect bone density in male rats.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

HSPGs help control stem cell behavior, affecting hair growth and offering a target for hair loss treatments.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Muscles can make their own androgens, which may help muscle growth.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

DHT stops hair regrowth in mice, similar to human hair loss.

Certain Dibenzo derivatives may help treat prostate cancer.